As of Sep 30, 2024, Edwards Lifesciences Corporation's fair value using the Ben Graham formula is $183.7 per share. This is calculated using Ben Graham formula, where EPS is $6.9 and BVPS (Book Value Per Share) is $16.0. The current price of $69.8 suggests Edwards Lifesciences Corporation may be overvalued by this conservative metric.
Edwards Lifesciences Corporation earnings per share (EPS) for the twelve months ending Sep 30, 2024, was $6.9, a 11.2% growth year-over-year.
Edwards Lifesciences Corporation's margin of safety is positive 163.2%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.